Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer-Reference-Cited by-同舟云学术

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

Published:2001-09-15 Issue:18 Volume:19 Page:3817-3827
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Goldhirsch Aron¹,Glick John H.¹,Gelber Richard D.¹,Coates Alan S.¹,Senn Hans-Jörg¹

Affiliation:

1. From the International Breast Cancer Study Group, Oncology Institute of Southern Switzerland, Lugano, and Zentrum für Tumordiagnostik und Prävention, St Gallen, Switzerland; European Institute of Oncology, Milan, Italy; University of Pennsylvania Cancer Center, Philadelphia, PA; Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA; and Australian Cancer Society and University of Sydney, East Sydney, Australia.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2001.19.18.3817

Reference83 articles.

1. Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

2. Ovarian ablation in early breast cancer: overview of the randomised trials

3. Tamoxifen for early breast cancer: an overview of the randomised trials

4. Polychemotherapy for early breast cancer: an overview of the randomised trials

5. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials

Cited by 550 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD10 expression as a potential predictor of pathological complete response in ER-negative and triple-negative breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy;Experimental and Molecular Pathology;2024-02

2. Predictive factors for complete pathological response in hormone receptor-negative breast cancer patients undergoing neoadjuvant chemotherapy;Pathology - Research and Practice;2024-02

3. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors;PeerJ;2022-12-15

4. Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland;Cancers;2022-03-04

5. Increasing Imaging Value to Breast Cancer Care Through Prognostic Modeling of Multiparametric MRI Features in Patients Undergoing Neoadjuvant Chemotherapy;Academic Radiology;2022-01